← Leaderboards
Sacha Gnjatic
Icahn School Of Medicine At Mount Sinai
$20,887,220
Attributed
$25,742,243
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $13.6M · FY2017–25$20M$15M$10M$5M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$25,742,243 · 6
By mechanism
U24$19,427,674 · 1
U01$2,881,766 · 1
N02$2,712,342 · 1
P30$720,461 · 3
Top collaborators
- Jean-Frederic Colombel5 shared
- Jeremiah James Faith5 shared
- Seunghee Kim-Schulze3 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Jeremiah James Faith$16,695,707
- Miriam Merad$28,468,631
- Jean-Frederic Colombel$960,589
- Joseph Scarpa$580,310
- Seunghee Kim-Schulze$2,933,846
Others in their field
Other Emerging Leaders on “Immunologist”
- Cara L Haymaker · University Of Tx Md Anderson Can Ctr$5,881,654
- Gheath Al-Atrash · University Of Tx Md Anderson Can Ctr$5,881,654
- Rebecca R Pompano · University Of Virginia$5,078,810
- Patrick R Secor · University Of Montana$4,793,350
- Suchismita Acharya · Ayuvis Research, Inc.$4,173,619
- Esak Lee · Cornell University$3,625,376
Research focus
ImmunologistResponseBloodMicrobiomeMalignant NeoplasmsImmuneTranscriptomicsCellsTissuesProteomicsCancer PatientProteinsImmunologic MonitoringImmune Checkpoint BlockadeData SetSamplingHigh DimensionalityPhenotypeFundingCancer ImmunotherapyMolecularImmunotherapy TrialsInnovationLaboratories
Grant awards (16)
High-Dimensional Immune Monitoring of NCI-Supported Immunotherapy Trials$1,992,193
U24 · FY2025 · CA · contact PI
Human Immune Monitoring Center$118,531
P30 · FY2025 · CA · contact PI
High-Dimensional Immune Monitoring of NCI-Supported Immunotherapy Trials$1,891,928
U24 · FY2024 · CA · contact PI
Characterizing and predicting colitis in immune checkpoint blockade-treated cancer patients$554,399
U01 · FY2024 · DK · contact PI
Human Immune Monitoring Center$120,386
P30 · FY2024 · CA · contact PI
High-Dimensional Immune Monitoring of NCI-Supported Immunotherapy Trials$1,983,570
U24 · FY2023 · CA · contact PI
Characterizing and predicting colitis in immune checkpoint blockade-treated cancer patients$577,498
U01 · FY2023 · DK · contact PI
Human Immune Monitoring Center$120,386
P30 · FY2023 · CA · contact PI
Characterizing and predicting colitis in immune checkpoint blockade-treated cancer patients$577,498
U01 · FY2022 · DK · contact PI
Human Immune Monitoring Center$120,386
P30 · FY2022 · CA · contact PI
CYTOF AND O-LINK ASSESSMENT IN THE `NCI COVID-19 IN CANCER PATIENTS STUDY' (NCCAPS)$2,712,342
N02 · FY2021 · CA · contact PI
Characterizing and predicting colitis in immune checkpoint blockade-treated cancer patients$577,498
U01 · FY2021 · DK · contact PI
Human Immune Monitoring Center$120,386
P30 · FY2021 · CA · contact PI
Characterizing and predicting colitis in immune checkpoint blockade-treated cancer patients$594,873
U01 · FY2020 · DK · contact PI
Human Immune Monitoring Center$120,386
P30 · FY2020 · CA · contact PI
High-Dimensional Immune Monitoring of NCI-Supported Immunotherapy Trials$13,559,983
U24 · FY2017 · CA · contact PI